Skip to Main Content

SKINVIVE™ by JUVÉDERM® Safety Information

SKINVIVE™ is from the world’s #1 brand of hyaluronic acid facial fillers1,* and has undergone extensive clinical testing.2–6

To determine if SKINVIVE™ by JUVÉDERM® is right for you, your healthcare practitioner will ask about your medical history.

SKINVIVE™ by JUVÉDERM® is not suitable for you if:7

  • You have untreated epilepsy
  • You tend to develop hypertrophic scarring
  • You have allergies to hyaluronic acid or other filler products, or allergies to lidocaine or other local anaesthetics
  • You have a history of porphyria
  • You are pregnant or breastfeeding
  • You are under the age of 18 years

Make sure you tell your healthcare practitioner if:7

  • You have skin infections or inflammation such as acne or cold sores (as SKINVIVE™ by JUVÉDERM® must not be used in these areas)
  • You have recently had other skin surface treatments (such as laser treatment, skin peels or dermabrasion) or have previously used fillers
  • You have a history of autoimmune disease, autoimmune deficiency or being under immunosuppressive therapy
  • You have a history of severe and/or multiple allergies
  • You have a history of streptococcal disease (recurrent sore throats, acute rheumatic fever)
  • You are currently taking medications which prolong bleeding, such as acetylsalicylic acid (aspirin), non-steroidal anti-inflammatory drugs or anticoagulants

Please note that this is not an exhaustive list of what to discuss with your practitioner.

Potential side effects associated with SKINVIVE™ by JUVÉDERM® include temporary injection-site reactions such as redness, swelling, itching, pain, firmness, bumps, bruising, and discolouration. These reactions may occur immediately or may be delayed. As with any injection, there is a risk of infection. This is not a complete list of side effects. If inflammatory reactions persist for more than one week, or if any other side effects develop, seek medical attention as soon as possible.7

SKINVIVE™ by JUVÉDERM® is an injectable implant used for the treatment, by filling, of superficial cutaneous depressions such as fine lines and for additional improvement of skin quality attributes such as hydration and elasticity.7

Footnotes

  • *Based on HCP tracking market research involving over 1,700 HCPs from 16 international markets.1

References

  1. Allergan Aesthetics. Data on file. REF-108642. Juvéderm®, the world’s leading brand of hyaluronic acid facial fillers claim. March 2023.
  2. Allergan Aesthetics. Data on File INT/0185/2015. JUVÉDERM® manufacturing process.
  3. Niforos F et al. Clin Cosmet Investig Dermatol. 2019;12:791–798.
  4. Alexiades M et al. Dermatol Surg. 2023;49(7):682–688.
  5. Ogilvie P et al. J Cosmet Dermatol. 2020;19(5):1065–1070.
  6. Safa M et al. Clin Cosmet Investig Dermatol. 2022;15:411–426.
  7. Juvéderm® VOLITE DFU. 73655JR10. Revision 2019-09-09.

[Local markets to update reference 7 to locally available SKINVIVE™ DFU]

Website produced and funded by Allergan Aesthetics, an AbbVie company.

Directions for consumers

This content is intended for [insert country name] adult (>18yrs) audience only. You should always consult a healthcare professional to help you decide if SKINVIVE™ by JUVÉDERM® is right for you and provide you with a full list of side effects.

Directions for healthcare professionals

Patients may experience potential side effects with SKINVIVE™ by JUVÉDERM® facial filter, which include inflammatory reactions (redness, oedema, erythema, etc.), haematomas, induration or nodules, staining or discolourations at injection site, etc. Please refer to SKINVIVE™ by JUVÉDERM® Directions for Use (DFU) for a full list of adverse events.7

Adverse events should be reported. Reporting forms and information can be found at [insert local reporting information details]. Adverse events should also be reported to Allergan Aesthetics [insert local contact details for AE reporting].

ALL-SKV-230079 | January 2024